While working for the William J. Clinton Foundation, Dr. Akash Goel led the launch of India’s national Second Line ARV drug program that currently provides lifesaving medication to tens of thousands of individuals living with HIV/AIDS. Akash has also worked for The Boston Consulting Group, CNN’s Medical News Unit, the New York City Department of Health and Senator Kirsten Gillibrand.
Akash is a graduate of Harvard College and University of Michigan Medical School. His research interests are in population health, private sector engagement, medical technology and social enterprise.
He was named a New Leader by the Carnegie Council and a World Economic Forum Global Shaper. He is a fellow of the Nantucket Project and an Asia 21 Fellow of the Asia Society. In 2015, Akash was awarded a Cannes Lion and recognized by the United Nations for his work in human rights advocacy.